Research Papers

25 of 234 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Mass spectrometry analysis of human tear fluid biomarkers specific for ocular and systemic diseases in the context of 3…
Zhan X; Li J; Guo Y; Golubnitschaja O.
EPMA J (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments ta…
Koklesova L; Mazurakova A; Samec M; Biringer K; Samuel SM; Büsselberg D; Kubatka P; Golubnitschaja O.
EPMA J (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Association of systemic inflammation indices with visual field loss progression in patients with primary angle-closure …
Li S; Qiu Y; Yu J; Shao M; Li Y; Cao W; Sun X.
EPMA J (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Personalization of medical treatments in oncology: time for rethinking the disease concept to improve individual outcom…
Bizzarri M; Fedeli V; Monti N; Cucina A; Jalouli M; Alwasel SH; Harrath AH.
EPMA J (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
All around suboptimal health - a joint position paper of the Suboptimal Health Study Consortium and European Associatio…
Wang W; Yan Y; Guo Z; Hou H; Garcia M; Tan X; Anto EO; Mahara G; Zheng Y; Li B; Kang T; Zhong Z; Wang Y; Guo X; Golubnitschaja O; Suboptimal Health Study Consortium and European Association for Predictive; Preventive and Personalised Medicine.
EPMA J (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Diagnosing hospital bacteraemia in the framework of predictive, preventive and personalised medicine using electronic h…
Garnica O; Gómez D; Ramos V; Hidalgo JI; Ruiz-Giardín JM.
EPMA J (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Caution, "normal" BMI: health risks associated with potentially masked individual underweight-EPMA Position Paper 2021.
Golubnitschaja O; Liskova A; Koklesova L; Samec M; Biringer K; Büsselberg D; Podbielska H; Kunin AA; Evsevyeva ME; Shapira N; Paul F; Erb C; Dietrich DE; Felbel D; Karabatsiakis A; Bubnov R; Polivka J; Polivka J; Birkenbihl C; Fröhlich H; Hofmann-Apitius M; Kubatka P.
EPMA J (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Wrist actigraphic approach in primary, secondary and tertiary care based on the principles of predictive, preventive an…
Acker J; Golubnitschaja O; Büttner-Teleaga A; Richter K.
EPMA J (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Endothelin-1 axes in the framework of predictive, preventive and personalised (3P) medicine.
Torres Crigna A; Link B; Samec M; Giordano FA; Kubatka P; Golubnitschaja O.
EPMA J (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Targeting phytoprotection in the COVID-19-induced lung damage and associated systemic effects-the evidence-based 3PM pr…
Liskova A; Koklesova L; Samec M; Abdellatif B; Zhai K; Siddiqui M; Šudomová M; Hassan STS; Kudela E; Biringer K; Giordano FA; Büsselberg D; Golubnitschaja O; Kubatka P.
EPMA J (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Complex analysis of the personalized pharmacotherapy in the management of COVID-19 patients and suggestions for applica…
Wang LY; Cui JJ; OuYang QY; Zhan Y; Wang YM; Xu XY; Yu LL; Yin H; Wang Y; Luo CH; Guo CX; Yin JY.
EPMA J (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Metabo-tip: a metabolomics platform for lifestyle monitoring supporting the development of novel strategies in predicti…
Brunmair J; Bileck A; Stimpfl T; Raible F; Del Favero G; Meier-Menches SM; Gerner C.
EPMA J (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Sleep quality and COVID-19 outcomes: the evidence-based lessons in the framework of predictive, preventive and personal…
Richter K; Kellner S; Hillemacher T; Golubnitschaja O.
EPMA J (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Flavonoids as an effective sensitizer for anti-cancer therapy: insights into multi-faceted mechanisms and applicability…
Liskova A; Samec M; Koklesova L; Brockmueller A; Zhai K; Abdellatif B; Siddiqui M; Biringer K; Kudela E; Pec M; Gadanec LK; Šudomová M; Hassan STS; Zulli A; Shakibaei M; Giordano FA; Büsselberg D; Golubnitschaja O; Kubatka P.
EPMA J (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Mitochondrial impairments in aetiopathology of multifactorial diseases: common origin but individual outcomes in contex…
Koklesova L; Samec M; Liskova A; Zhai K; Büsselberg D; Giordano FA; Kubatka P; Golunitschaja O.
EPMA J (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Challenging management of severe chronic disorders in acute pandemic situation: Chronic liver disease under COVID-19 pa…
Skladany L; Koller T; Adamcova Selcanova S; Vnencakova J; Jancekova D; Durajova V; Laffers L; Svac J; Janickova K; Palkovič M; Kohout P; Golubnitschaja O.
EPMA J (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Induced sputum metabolomic profiles and oxidative stress are associated with chronic obstructive pulmonary disease (COP…
Zhu T; Li S; Wang J; Liu C; Gao L; Zeng Y; Mao R; Cui B; Ji H; Chen Z.
EPMA J (Unknown)
Published: 2020
3/6 Transparent
Data Funding Declared
Infections of the lung: a predictive, preventive and personalized perspective through the lens of evolution, the emerge…
Ahluwalia P; Ahluwalia M; Vaibhav K; Mondal A; Sahajpal N; Islam S; Fulzele S; Kota V; Dhandapani K; Baban B; Rojiani AM; Kolhe R.
EPMA J (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Voice perturbations under the stress overload in young individuals: phenotyping and suboptimal health as predictors for…
Kunin A; Sargheini N; Birkenbihl C; Moiseeva N; Fröhlich H; Golubnitschaja O.
EPMA J (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Cell-free nucleic acid patterns in disease prediction and monitoring-hype or hope?
Crigna AT; Samec M; Koklesova L; Liskova A; Giordano FA; Kubatka P; Golubnitschaja O.
EPMA J (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Prostate cancer management: long-term beliefs, epidemic developments in the early twenty-first century and 3PM dimensio…
Kucera R; Pecen L; Topolcan O; Dahal AR; Costigliola V; Giordano FA; Golubnitschaja O.
EPMA J (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Flavonoids against the Warburg phenotype-concepts of predictive, preventive and personalised medicine to cut the Gordia…
Samec M; Liskova A; Koklesova L; Samuel SM; Zhai K; Buhrmann C; Varghese E; Abotaleb M; Qaradakhi T; Zulli A; Kello M; Mojzis J; Zubor P; Kwon TK; Shakibaei M; Büsselberg D; Sarria GR; Golubnitschaja O; Kubatka P.
EPMA J (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Differences in cohort study data affect external validation of artificial intelligence models for predictive diagnostic…
Birkenbihl C; Emon MA; Vrooman H; Westwood S; Lovestone S; AddNeuroMed Consortium; Hofmann-Apitius M; Fröhlich H; Alzheimer’s Disease Neuroimaging Initiative.
EPMA J (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Anti-parasite drug ivermectin can suppress ovarian cancer by regulating lncRNA-EIF4A3-mRNA axes.
Li N; Zhan X.
EPMA J (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Microbial and metabolomic analysis of gingival crevicular fluid in general chronic periodontitis patients: lessons for …
Pei J; Li F; Xie Y; Liu J; Yu T; Feng X.
EPMA J (Unknown)
Published: 2020
3/6 Transparent
Data Funding Declared